Hematology
From the Journals
Real-world outcomes of caplacizumab for iTTP comparable to clinical trial results
Conference Coverage
Close joint health monitoring essential with new hemophilia therapies
Conference Coverage
Type 3 von Willebrand a rare but serious bleeding disorder
Conference Coverage
Bleeding disorder diagnoses delayed by years in girls and women
From the Journals
‘Phenomenal’ results with CAR T cells in R/R multiple myeloma
From the Journals
New ASH guidelines: VTE prevention and treatment in cancer patients
Conference Coverage
Safety profiles of hemophilia agents vary widely
Conference Coverage
Steroid complications in GVHD common, boost costs of care
Conference Coverage
Factor VIII concentrate is here to stay in hemophilia A
From the Journals
CLL, MBL had lower response rates to flu vaccination, compared with healthy adults
Patients with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis were assessed for their immune response.
News
FDA okays new CAR T-cell treatment for large B-cell lymphomas